Cours InDex Pharmaceuticals Holding AB (publ) Nasdaq Stockholm
Actions
SE0008966295
Produits pharmaceutiques
CA 2024 * | - | CA 2025 * | - | Capitalisation | 196 M 2,14 Md 179 M |
---|---|---|---|---|---|
Résultat net 2024 * | -259 M -2,82 Md -236 M | Résultat net 2025 * | -221 M -2,41 Md -202 M | VE / CA 2024 * | - |
Dette nette 2024 * | 86,32 M 941 M 78,82 M | Dette nette 2025 * | 306 M 3,34 Md 279 M | VE / CA 2025 * | - |
PER 2024 * |
-0,75
x | PER 2025 * |
-0,9
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 62,47% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Jenny Sundqvist
CEO | Chief Executive Officer | 53 | 01/01/23 |
Johan Gileus
DFI | Director of Finance/CFO | 59 | 01/05/17 |
Charlotte Admyre
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Uli Alf Hacksell
BRD | Director/Board Member | 74 | 01/01/16 |
Director/Board Member | 68 | 01/01/11 | |
Chairman | 72 | 01/01/11 |
Varia. 1 janv. | Capi. | |
---|---|---|
+25,83% | 661 Md | |
+27,00% | 566 Md | |
-6,76% | 352 Md | |
+20,34% | 332 Md | |
+3,00% | 283 Md | |
+13,09% | 231 Md | |
+5,46% | 200 Md | |
-9,61% | 195 Md | |
-6,26% | 145 Md |